tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
BEAM
Beam Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Beam Therapeutics (BEAM) Stock News & Sentiment

Compare
1,495 Followers
Beam Therapeutics Receives Buy Rating on Promising Sickle Cell Therapy Data and Market Potential
Premium
Ratings
Beam Therapeutics Receives Buy Rating on Promising Sickle Cell Therapy Data and Market Potential
2d ago
BEAM
Bullish Outlook on Beam Therapeutics Driven by Promising Clinical Data and Market Opportunities
Premium
Ratings
Bullish Outlook on Beam Therapeutics Driven by Promising Clinical Data and Market Opportunities
2d ago
BEAM
Positive Outlook for Beam Therapeutics’ BEAM-101 in Sickle Cell Disease Treatment Justifies Buy Rating
Premium
Ratings
Positive Outlook for Beam Therapeutics’ BEAM-101 in Sickle Cell Disease Treatment Justifies Buy Rating
3d ago
BEAM
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease, Justifying Buy Rating
Premium
Ratings
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease, Justifying Buy Rating
3d ago
BEAM
Beam Therapeutics’ BEAM-101: Promising Advancements in Sickle Cell Disease Treatment with Strong Phase 1/2 Trial Results
Premium
Ratings
Beam Therapeutics’ BEAM-101: Promising Advancements in Sickle Cell Disease Treatment with Strong Phase 1/2 Trial Results
6d ago
BEAM
Beam Therapeutics Confirms Key Decisions at Annual Meeting
Premium
Company Announcements
Beam Therapeutics Confirms Key Decisions at Annual Meeting
13d ago
8K
BEAM
Beam Therapeutics: Promising Gene Editing Advancements and Strategic Execution Reinforce Buy Rating
Premium
Ratings
Beam Therapeutics: Promising Gene Editing Advancements and Strategic Execution Reinforce Buy Rating
1M ago
BEAM
More BEAM News >

BEAM News on the Web

Gene-Editing Stocks Gain on LLY-VERV Deal Announcement
Zacks
Neutral
Why Beam Therapeutics Inc.amp;#8217;s (BEAM) Stock Is Up 6.65%
AAII
Neutral
CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?
Zacks
Neutral
Why Beam Therapeutics Inc.amp;#8217;s (BEAM) Stock Is Up 6.68%
AAII
Neutral
Beam Therapeutics (BEAM) Up 5.7% Since Last Earnings Report: Can It Continue?
Zacks
Neutral
BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
Zacks
Neutral
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?
Zacks
Neutral
Why Beam Therapeutics Inc.amp;#8217;s (BEAM) Stock Is Up 5.09%
AAII
Neutral

News Score - Last 7 Days

Neutral
BEAM
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BEAM’s Media Buzz Sentiment?
1 articles about BEAM were published this week. In an average week, 2 articles are published.
    What is BEAM’s weekly average amount of articles?
    In an average week, 2 articles about BEAM are published.
      What is BEAM’s News Sentiment?
      50% of articles about BEAM were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        OGNOrganon
        VERVVerve Therapeutics
        PDEXPro-Dex
        USNAUSANA Health
        AVDLAvadel Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing